Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Skip to main content
Elham Amini. E.A

Elham Amini. E.A

Thyroid hormones (THs) L-thyroxine and L-triiodothyronine, primarily known as metabolism regulators, are tyrosine-derived hormones produced by the thyroid gland. They play an essential role in normal central nervous system... more
Thyroid  hormones  (THs)  L-thyroxine  and  L-triiodothyronine,  primarily  known  as  metabolism
regulators, are tyrosine-derived hormones produced by the thyroid gland. They play an essential role
in  normal  central  nervous  system  development  andphysiological  function.  By  binding  to  nuclear
receptors  and  modulating  gene  expression,  THs  influence  neuronal  migration,  differentiation,
myelination, synaptogenesis and neurogenesis in developing and adult brains. Any uncorrected THs
supply  deficiency  in  early  life  may  result  inirreversible  neurological  and  motor  deficits.The
development  and  function  of  GABAergic  neurons  as  well  as  glutamatergic  transmission  are  also
affected by THs. Though the underlying molecular mechanisms still remainunknown, the effects of
THs  on  inhibitory  and  excitatory  neurons  may  affect  brain  seizure  activity.  The  enduring
predisposition  of  the  brain  to  generate  epileptic  seizures  leads  to  a  complex  chronic  brain  disorder
known  as  epilepsy.  Pathologically,  epilepsy  may  be  accompanied  bymitochondrial  dysfunction,
oxidative stress and eventually dysregulation of excitatory glutamatergic and inhibitory GABAergic
neurotransmission.  Based  on  the  latest  evidence  on  the  association  between  THs  and  epilepsy,  we
hypothesizes that THs abnormalities may contribute to the pathogenesis of epilepsy. We also review
gender differences and the presumed underlying  mechanisms through  which TH abnormalities may
affect epilepsyhere.
Research Interests:
Glycogen synthase kinase 3 (GSK-3) dysregulation plays an important role in the pathogenesis of numerous disorders, affecting the central nervous system (CNS) encompassing both neuroinflammation and neurodegenerative diseases. Several... more
Glycogen synthase kinase 3 (GSK-3) dysregulation plays an important role in the pathogenesis of numerous disorders, affecting the central nervous system (CNS) encompassing both neuroinflammation and neurodegenerative diseases. Several lines of evidence have illustrated a key role of the GSK-3 and its cellular and molecular signaling cascades in the control of neuroinflammation. Glycogen synthase kinase 3 beta (GSK-3ß), one of the GSK-3 isomers, plays a major role in neuronal apoptosis and its inhibition decreases expression of alphaSynuclein (a-Synuclein), which make this kinase an attractive therapeutic target for neurodegenerative disorders.
Parkinson's disease (PD) is a chronic neurodegenerative movement disorder characterized by the progressive and massive loss of dopaminergic neurons by neuronal apoptosis in the substantia nigra pars compacta and depletion of dopamine in the striatum, which lead to pathological and clinical abnormalities. Thus, understanding the role of GSK-3ß in PD will enhance our knowledge of the basic mechanisms underlying the pathogenesis of this disorder and facilitate the identification of new therapeutic avenues. In recent years, GSK-3ß has been shown to play essential roles in modulating a variety of cellular functions, which have prompted efforts to develop GSK-3ß inhibitors as therapeutics.
In this review, we summarize GSK-3 signaling pathways and its association with neuroinflammation. Moreover, we highlight the interaction between GSK-3ß and several cellular processes involved in the pathogenesis of PD, including the accumulation of a-Synuclein aggregates, oxidative stress and mitochondrial dysfunction. Finally, we discuss about GSK-3ß inhibitors as a potential therapeutic strategy in PD.
Research Interests:
Research Interests: